Over-the-counter (OTC) medicines, drugs available to consumers/patients without a prescription, play an important role in our modern healthcare system. An upcoming Consumer Healthcare Products Association workshop highlights how USP collaborates with key stakeholders to help address specific needs in OTC manufacturing and testing related to drug quality. Learn more.
In LMICs, the availability of medicines manufactured locally that do not meet quality standards is a leading cause of treatment failure and adverse events in patients and is undermining public health interventions. But where do things go wrong during pharmaceutical manufacturing in LMICs that give rise to this problem? Learn more.
Desmond Hunt, Ph.D., USP’s Senior Scientific Liaison, provides insight into metal packaging systems for drugs and how USP standards can support quality in this field. Dr. Hunt works closely with USP’s Expert Committee on Packaging and Distribution—the volunteer experts who serve as key decision-makers in the USP standards-setting process. Learn more.
Discover convenient tools and helpful tips related to using USP Reference Standards in your work. USP Reference Standards are intended for quality control use in conducting assays and tests in USP’s documentary standards for drugs, dietary supplements, and foods.
Plastic packaging systems play an important role in protecting the drugs we use. However, a drug’s packaging must be compatible with the product and not compromise its stability, efficacy or safety. USP’s Desmond Hunt, Ph.D., provides insight into plastic packaging systems for drugs and how USP standards can support quality in this field.
Pharmacopeial Forum (PF) is the vehicle through which USP publishes proposed revisions to USP–NF standards for public review and comment. Learn about PF and how you can use it to help shape standards for drugs, excipients and dietary supplements.
Dissolution, disintegration and drug release tests are important tools during the entire lifecycle of a drug product, from early development throughout its shelf life. USP’s Margareth Marques, Ph.D., provides answers to common questions and insight into standards and resources for these tests.
Gigi Davidson, R.Ph., DICVP, Chair of USP's Compounding Expert Committee shares her thoughts and background information on proposed revisions to <797> Pharmaceutical Compounding—Sterile Preparations. Compounding practitioners are encouraged to view and share comments on the changes online.
Nuclear medicine and medical imaging, such as PET scans, have changed how many diseases (e.g., cancer, Alzheimer's) are evaluated and treated. Learn how USP is updating its standards to reflect “state-of-the-industry” practices in this field.